Subcutaneous · GLP-1 agonist
Zovaglutide
11 trials in this molecule. Source: ClinicalTrials.gov, as of November 5, 2026.
Trials
11
Ongoing
6
Recruiting
0
Completed
5
Sites
65
Countries
2
Endpoints
94
Composite endpoints
0
Distinct sites and countries across this molecule's trials. A site running several of its trials counts once, matching the map.
Where the program stands
Trials by phase
Phase 1
7
Phase 1/2
1
Phase 2
2
Phase 3
1
Trials by status
Not yet recruiting
2
Active, not recruiting
4
Completed
5
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Safety / tolerability / PK
58
Weight & body composition
18
Other (unclassified)
14
Cardiometabolic biomarkers
2
Glycemic / diabetes
1
Other clinical outcomes
1
Top 20 metrics across this asset's endpoints
Programs for this asset
Every trial for this molecule, with the same search, filters, and sort as the Trials tab.
⌘K
11 of 11
Showing 1-11 of 11 trials